From August 29, 2023 to September 30, 2023, the company has repurchased 355,110 shares, representing 1.74% for CAD 0.24 million. With this, the company has completed the repurchase of 355,110 shares, representing 1.74% for CAD 0.24 million under the buyback announced on August 29, 2023.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.42 CAD | -2.33% | -10.64% | -14.29% |
May. 08 | Crescita Therapeutics Q1 Loss Widens, Revenue Rises | MT |
May. 08 | Crescita Therapeutics Brief: Q1 Revenue was $4.996 Million | MT |
1st Jan change | Capi. | |
---|---|---|
-14.29% | 5.99M | |
+38.16% | 727B | |
+30.73% | 592B | |
-7.54% | 347B | |
+15.60% | 319B | |
+0.73% | 274B | |
+12.25% | 238B | |
+6.87% | 204B | |
-5.77% | 203B | |
-3.04% | 160B |
- Stock Market
- Equities
- CTX Stock
- News Crescita Therapeutics Inc.
- Tranche Update on Crescita Therapeutics Inc.'s Equity Buyback Plan announced on August 29, 2023.